The Systemic-immune-inflammation Index Independently Predicts Survival and Recurrence in Resectable Pancreatic Cancer and its Prognostic Value Depends on Bilirubin Levels A Retrospective Multicenter Cohort Study

被引:230
作者
Aziz, Mohammad Hosein [1 ]
Sideras, Kostandinos [1 ]
Aziz, Nasir Ahmad [2 ]
Mauff, Katya [3 ]
Haen, Roel [4 ]
Roos, Daphne [4 ]
Saida, Lawlaw [5 ]
Suker, Mustafa [1 ]
van der Harst, Erwin [6 ]
Mieog, Jan Sven [7 ]
Bonsing, Bert A. [7 ]
Klaver, Yarne [8 ]
Koerkamp, Bas Groot [1 ]
van Eijck, Casper H. [1 ]
机构
[1] Erasmus MC, Dept Surg, Room H-818ks Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands
[2] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands
[3] Erasmus Univ, Med Ctr, Dept Biostat, Rotterdam, Netherlands
[4] Reinier de Graaf Gasthuis, Dept Surg, Delft, Netherlands
[5] Vrije Univ, Dept Hlth Sci, Amsterdam, Netherlands
[6] Maasstad Hosp, Dept Surg, Rotterdam, Netherlands
[7] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands
[8] Erasmus Univ, Med Ctr, Lab Tumor Immunol, Dept Med Oncol, Rotterdam, Netherlands
关键词
obstructive jaundice; pancreatic cancer; pancreatic ductal adenocarcinoma; prognostic biomarkers; survival; systemic-immune-inflammation-index; LYMPHOCYTE RATIO; DUCTAL ADENOCARCINOMA; PREOPERATIVE PLATELET; CURATIVE RESECTION; NEUTROPHIL; SURGERY; HEAD;
D O I
10.1097/SLA.0000000000002660
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: Our aim was to determine the prognostic significance of the systemic-immune-inflammation index (SIII) in patients with resectable pancreatic cancer, using cancer-specific survival as the primary outcome. Background: Pancreatic cancer is associated with a dysfunctional immune system and poor prognosis. We examined the prognostic significance of the SIII in patients with resectable pancreatic ductal adenocarcinoma (PDAC) and the effects of bilirubin on this index. Methods: We retrospectively assessed all pancreatic resections performed between 2004 and 2015 at 4 tertiary referral centers to identify pathologically confirmed PDAC patients. Baseline clinicopathologic characteristics, preoperative laboratory values such as absolute neutrophil, lymphocyte, and platelet counts, C-reactive protein, albumin, bilirubin, and CA19-9 levels, and also follow-up information, were collected. The associations of the calculated inflammatory indices with outcome were both internally and externally validated. Results: In all, 590 patients with resectable PDAC were included. The discovery and validation cohort included 170 and 420 patients, respectively. SIII > 900 [hazard ratio (HR) 2.32, 95% confidence interval (CI) 1.55-3.48], lymph node ratio (HR 3.75, 95% CI 2.08-6.76), and CA19.9 > 200 kU/L (HR 1.62, 95% CI 1.07-2.46) were identified as independent predictors of cancer-specific survival. Separate model analysis confirmed that preoperative SIII contributed significantly to prognostication. However, SIII appeared to lose its prognostic significance in patients with bilirubin levels above 200 mu mol/L. Conclusions: SIII is an independent predictor of cancer-specific survival and recurrence in patients with resectable PDAC. SIII may lose its prognostic significance in patients with high bilirubin levels. Properly designed prospective studies are needed to further confirm this hypothesis.
引用
收藏
页码:139 / 146
页数:8
相关论文
共 50 条
[1]  
[Anonymous], SCI IMMUNOL
[2]  
[Anonymous], 1973, P 2 INT S INF THEOR, DOI [10.1007/978-1-4612-1694-0, 10.1007/978-1-4612-0919-5_38]
[3]  
[Anonymous], TREATMENT POTENTIALL
[4]  
[Anonymous], 2010, R: A Language and Environment for Statistical Computing
[5]   Substaging of Lymph Node Status in Resected Pancreatic Ductal Adenocarcinoma Has Strong Prognostic Correlations: Proposal for a Revised N Classification for TNM Staging [J].
Basturk, Olca ;
Saka, Burcu ;
Balci, Serdar ;
Postlewait, Lauren M. ;
Knight, Jessica ;
Goodman, Michael ;
Kooby, David ;
Sarmiento, Juan M. ;
El-Rayes, Bassel ;
Choi, Hyejeong ;
Bagci, Pelin ;
Krasinskas, Alyssa ;
Quigley, Brian ;
Reid, Michelle D. ;
Akkas, Gizem ;
Maithel, Shishir K. ;
Adsay, Volkan .
ANNALS OF SURGICAL ONCOLOGY, 2015, 22 :S1187-S1195
[6]   Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinorna of the pancreas [J].
Brown, KM ;
Domin, C ;
Aranha, GV ;
Yong, S ;
Shoup, M .
AMERICAN JOURNAL OF SURGERY, 2005, 189 (03) :278-282
[7]   Pretreatment neutrophil-to-lymphocyte ratio is correlated with response to neoadjuvant chemotherapy as an independent prognostic indicator in breast cancer patients: a retrospective study [J].
Chen, Yi ;
Chen, Kai ;
Xiao, Xiaoyun ;
Nie, Yan ;
Qu, Shaohua ;
Gong, Chang ;
Su, Fengxi ;
Song, Erwei .
BMC CANCER, 2016, 16
[8]   Rationally combining immunotherapies to improve efficacy of immune checkpoint blockade in solid tumors [J].
Dammeijer, Floris ;
Lau, Sai Ping ;
van Eijck, Casper H. J. ;
van der Burg, Sjoerd H. ;
Aerts, Joachim G. J. V. .
CYTOKINE & GROWTH FACTOR REVIEWS, 2017, 36 :5-15
[9]   Preoperative CEA and CA 19-9 are prognostic markers for survival after curative resection for ductal adenocarcinoma of the pancreas - A retrospective tumor marker prognostic study [J].
Distler, Marius ;
Pilarsky, Eva ;
Kersting, Stephan ;
Gruetzmann, Robert .
INTERNATIONAL JOURNAL OF SURGERY, 2013, 11 (10) :1067-1072
[10]   A systematic review of the prognostic value of lymph node ratio, number of positive nodes and total nodes examined in pancreatic ductal adenocarcinoma [J].
Elshaer, M. ;
Gravante, G. ;
Kosmin, M. ;
Riaz, A. ;
Al-Bahrani, A. .
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2017, 99 (02) :101-106